Il mercato dei farmaci da banco e degli integratori alimentari è stato valutato a 2.93.255,40 milioni di dollari nel 2019 e si prevede che raggiungerà 4.92.102,49 milioni di dollari entro il 2027; si prevede che crescerà a un CAGR del 6,8% dal 2020 al 2027.
I farmaci da banco (OTC) sono disponibili al pubblico per il loro uso generale. Questi farmaci non necessitano di prescrizione medica. I medicinali da banco sono disponibili per varie esigenze mediche. condizioni come tosse e raffreddore, diarrea, bruciore di stomaco, stitichezza, acne, dolore e altri. D'altra parte, gli integratori alimentari sono disponibili da banco per scopi di fitness. Tuttavia, l'acquisto di un integratore alimentare con ingredienti medicinali richiede la prescrizione di un medico quando una persona è gravemente malata o necessita di cure. Questi farmaci da banco e integratori alimentari hanno due forme: di marca o generici.
L'ambito del mercato dei farmaci da banco e degli integratori alimentari comprende prodotto, tipo, forma, canale di distribuzione e regione. Il mercato dei farmaci da banco e degli integratori alimentari viene analizzato sulla base di regioni come Nord America, Europa, Asia Pacifico, Medio Oriente e Stati Uniti. Africa e America meridionale e centrale. Il rapporto offre approfondimenti e analisi approfondite del mercato dei farmaci da banco e degli integratori alimentari, sottolineando vari parametri quali tendenze di mercato, progressi tecnologici, dinamiche di mercato e analisi del panorama competitivo dei principali attori del mercato in tutto il mondo.
Approfondimenti strategici
Regioni redditizie per il mercato dei farmaci da banco e degli integratori alimentariApprofondimenti di mercato
Crescente consapevolezza riguardo ai problemi di salute generale
Le persone al giorno d'oggi sono ben consapevoli dei problemi di salute generale come raffreddore, tosse, allergie, febbre, dolore, acidità, diarrea e condizioni legate alla pelle. La maggior parte della popolazione si concentra sull’adozione di uno stile di vita sano evitando il consumo di cibo spazzatura che porta ad un aumento delle malattie legate allo stile di vita come il diabete, l’obesità e le malattie cardiovascolari. La crescente preferenza verso il mantenimento di uno stile di vita sano porta anche al consumo di prodotti dimagranti e integratori alimentari, come vitamine, minerali e integratori. L'aumento dell'esposizione a Internet ha portato a un maggiore accesso agli integratori alimentari e ai farmaci da banco (OTC) per i consumatori, a prezzi accessibili.
I comuni problemi di salute possono essere stagionali o potrebbero verificarsi a causa di piccoli cambiamenti nelle abitudini di routine; quindi, le persone preferiscono assumere farmaci da banco per curarli invece di visitare un medico. In molti casi, ciò consente di risparmiare tempo e denaro e fornisce un sollievo immediato. Diversi governi hanno avviato vari programmi di sensibilizzazione sulla salute, grazie ai quali si è verificata un'adozione rapida e agevole della tecnologia quotidiana per l'assistenza sanitaria e il benessere, contribuendo alla crescita complessiva del settore. In India, ad esempio, il governo sta adottando misure positive verso la formalizzazione dell’uso dei medicinali da banco. I programmi di monitoraggio delle prescrizioni (PMP) raccolgono, monitorano e analizzano i dati di prescrizione e dispensazione trasmessi elettronicamente inviati dalle farmacie e dai professionisti della dispensazione. Questi dati vengono poi utilizzati per prevenire l’abuso di farmaci da banco. Pertanto, promuovendo la vendita di farmaci da banco.
I progressi nel settore farmaceutico, come la modellazione predittiva, le app mobili, la robotica e la diagnostica, stanno aprendo nuove strade per i farmacisti , che possono migliorare la loro capacità di dispensare farmaci, ridurre al minimo gli errori e monitorare l'aderenza del paziente. Un medicinale correttamente dispensato non comporterà alcun tipo di abuso di farmaci, il che rafforza ulteriormente la fiducia nel riacquisto di prodotti da banco e integratori alimentari. Pertanto, la consapevolezza delle preoccupazioni generali sulla salute e i progressi nel settore farmaceutico stanno guidando la crescita del mercato.
&n bsp;
Approfondimenti basati sui prodotti su farmaci OTC e integratori alimentari ; ' < /p>
In base al prodotto, il mercato dei farmaci da banco e degli integratori alimentari è segmentato in prodotti per la tosse e il raffreddore, vitamine e integratori alimentari, analgesici, prodotti gastrointestinali, sonniferi, prodotti per l'igiene orale, prodotti oftalmici, antiacidi, prodotti per l'igiene femminile, e altri.
Nel 2019, il segmento degli analgesici rappresentava la quota più elevata del mercato. La crescita di questo segmento è attribuita alla crescente consapevolezza riguardo ai problemi di salute generale e alla crescente preferenza per i farmaci senza prescrizione rispetto a quelli con prescrizione in tutto il mondo. Tuttavia, è probabile che i segmenti delle vitamine e degli integratori alimentari registreranno il CAGR più elevato nel mercato globale dei farmaci da banco e degli integratori alimentari durante il periodo di previsione.
&n bsp; &n bsp; &n bsp;
Mercato globale dei farmaci da banco e degli integratori alimentari, per tipo di farmaco e integratore alimentare da banco– 2019 e 2027Approfondimenti basati sul tipo
In base al tipo, il mercato dei farmaci da banco e degli integratori alimentari è segmentato in di marca e generico. Il segmento dei generici ha detenuto una quota maggiore del mercato nel 2019; mentre, si stima che lo stesso segmento registrerà un CAGR più elevato del 7,1% nel mercato durante il periodo di previsione.
Approfondimenti basati sulla forma
In base alla forma, il mercato dei farmaci da banco e degli integratori alimentari è segmentato in compresse, capsule, polveri, unguenti, liquidi , e altri. Il segmento dei tablet ha detenuto la quota maggiore del mercato nel 2019 e si stima che registrerà il CAGR più elevato del 7,5% nel mercato durante il periodo di previsione.
  ; '   ;
Canale di distribuzione basato sul canale di distribuzione, il mercato dei farmaci da banco e degli integratori alimentari è segmentato in ospedali e farmacie al dettaglio, negozi al dettaglio, canali online e altri. Il segmento ospedaliero e delle farmacie al dettaglio ha detenuto la quota maggiore del mercato nel 2019; tuttavia, si stima che il segmento dei canali online registrerà il CAGR più elevato del 7,5% nel mercato durante il periodo di previsione.
; '   ;
Lanci ed espansione di prodotti Le strategie sono comunemente adottate dalle aziende per espandere la propria presenza e il portafoglio di prodotti in tutto il mondo, nonché per soddisfare la crescente domanda.
Gli operatori di mercato che operano nel mercato dei farmaci da banco e degli integratori alimentari hanno adottato la strategia di innovazione del prodotto per soddisfare la mutevole domanda dei clienti in tutto il mondo, che consente inoltre ai giocatori di mantenere il proprio marchio a livello globale.
Per prodotto
< ul>
Per tipo ;
- Con marchio
- Generici
Per forma
- Compresse
- Capsule
- Polveri
- Unguenti
- Liquidi
- Altri
Per canale di distribuzione
- Ospedaliero e Farmacie al dettaglio
- Negozi al dettaglio
- Canali online
- Altro
Per area geografica
- Nord America
- Stati Uniti
- Canada
- Messico
- Europa
- Francia
- Germania
- Italia
- Regno Unito
- Spagna
- Asia Pacifico (APAC)
- Cina
- India
- Corea del Sud
- Giappone
- Australia
- Medio Oriente e altri paesi Africa (MEA)
- Sudafrica
- Arabia Saudita
- Emirati Arabi Uniti
- Sudamerica (SAM)< ul>
- Brasile
- Argentina
Profili aziendali
- GlaxoSmithKline plc.
- Sanofi
- Johnson and Johnson Services, Inc.
- Abbott
- AbbVie Inc.
- Bausch Health Companies Inc.
- Bayer AG
- Procter & Gamble
- Novartis AG
- Reckitt Benckiser Group Plc.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The use of OTC drugs to treat various health conditions has allowed saving healthcare expenditure. Also, the consumption of dietary supplements has helped in improving health and enhance immunity. Thus, the products have provided affordable treatment options for both consumers and the healthcare systems across the globe.
The growth of the market is attributed to growing awareness regarding general health issues and growing preference for non-prescription drugs over prescription drugs. However, the stringent FDA regulations related to safety and efficacy of OTC drugs is expected to hinder the market growth.
Over the counter (OTC) drugs are available for the public for their general use. These drugs do not require a prescription from a physician. OTC medicines are available for various medical symptoms due to medical conditions such as coughs and colds, diarrhea, heartburn, constipation, acne, pain, and others. On the other hand, dietary supplements are available over the counter for fitness purposes. Whereas, in some cases, when a person is critically ill or requires treatment, then buying a dietary supplement with medicinal ingredients requires a prescription from a physician. These OTC drugs and nutritional supplements have two forms, such as branded or generic.
The List of Companies - OTC Drug and Dietary Supplement Market
- GlaxoSmithKline plc.
- Sanofi
- Johnson and Johnson Services, Inc.
- Abbott
- AbbVie Inc.
- Bausch Health Companies Inc.
- Bayer AG
- Procter & Gamble
- Novartis AG
- Reckitt Benckiser Group Plc
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Aug 2020
Aquatic Veterinary Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Diagnostics and Treatments), Species (Fish, Crustaceans, Mollusca, and Others), Disease Source (Bacteria, Viruses, Parasites, and Others), Route of Administration (Water Medication, Medicated Feed, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Aug 2020
Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis By Treatment (Generic Drugs and Originators), Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Aug 2020
Malaria and Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Treatment [Malaria and Sickle Cell Disease (SCD)], Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Aug 2020
Pharmaceutical Contract Sales Organizations Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Services (Commercial Services and Non-Commercial Services), Modules (Syndicated Modules and Dedicated Modules), Therapeutic Area (Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases, and Others), End User (Biopharmaceutical Companies and Pharmaceutical Companies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Aug 2020
Breast Cancer Therapeutics Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Drug Therapy [Targeted Drug Therapy (Abemaciclib, Ado-Trastuzumab Emtansine, Palbociclib, Trastuzumab, and Other Target Drug Therapies), Hormonal Drug Therapy (Selective Estrogen Receptor Modulators, Aromatase Inhibitors, and Selective Estrogen Receptor Downregulators), Chemotherapy, and Immunotherapy/Biological Therapy], Breast Cancer Type (Hormone Receptor, HER2+, and Triple-Negative Breast Cancer), Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Pharmacies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Aug 2020
Radioactive Tracer Market
Size and Forecast to 2030 - Global Analysis by Tracer Type [Technetium-99m & Tc-97m, Iodine-131, Iron-59, Lutetium-171, Rubidium (Rb-82) Chloride & Ammonia (N-13), Scandium-46, Seaborgium-269, Hassium-269, Gallium Citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), Phosphorus-32 & Chromium-51, Thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and Others], Test Type (PET, SPECT, and Others), Application (Oncology, Pulmonary, Neurology, Cardiology, and Others) End User (Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, And Others), and Geography
Aug 2020
Glioma Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease (Astrocytoma, Oligoastrocytoma, and Oligodendroglioma), Treatment Type (Surgery, Chemotherapy, Radiation Therapy, and Others), Grade (Low Grade and High Grade), End User (Hospital & Clinics and Ambulatory Surgical Center), and Geography
Aug 2020
Hyperpigmentation Disorder Treatment Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Treatment Type (Cosmeceutical, Light or Laser Therapy, Microdermabrasion, Chemical Peels, Cryotherapy, and Others), Condition (Melasma, Solar Lentigines, Post-Inflammatory Hyperpigmentation, and Others), End User (Hospitals, Dermatology Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)